NSPR
InspireMD Inc
0.70$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.8% | 80.2% | 91.3% | 84.4% | 92.9% | 79.0% | 86.3% | 93.4% | 86.5% | 92.7% | 86.6% | 88.6% | |
| 55.0% | 56.4% | 79.9% | 60.7% | 76.4% | 55.8% | 71.1% | 30.2% | 18.8% | 20.2% | 40.4% | 12.9% | |
| 55.0% | 56.4% | 79.9% | 60.7% | 76.4% | 55.8% | 71.1% | 85.7% | 72.2% | 81.9% | 74.0% | 78.1% | |
| 8.7% | 9.5% | 5.5% | 13.9% | 6.7% | 9.8% | 5.3% | 3.5% | 5.1% | 3.8% | 4.8% | 3.7% | |
| 16.8% | 13.0% | 5.3% | 8.7% | 9.2% | 12.5% | 8.0% | 2.9% | 6.6% | 4.4% | 5.5% | 4.9% | |
| 5.4% | 8.2% | 4.0% | 7.8% | 3.4% | 5.5% | 2.5% | 4.3% | 10.0% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 124.3% | 151.0% | 57.0% | 55.3% | 28.7% | 45.5% | 31.6% | 15.6% | 29.4% | 17.1% | 22.9% | 20.5% | |
| 73.9% | 119.7% | 50.8% | 40.6% | 23.8% | 31.5% | 20.8% | 10.9% | 20.6% | 12.6% | 16.4% | 15.4% | |
| 33.2% | 71.8% | 28.5% | 0.0% | – | 3.7% | 2.3% | 1.1% | 1.7% | 1.2% | 1.2% | 1.5% | |
| 7.9% | 8.9% | 6.6% | 5.4% | 7.6% | 6.5% | 1.3% | 2.2% | 2.7% | 2.0% | 2.7% | 1.8% | |
| 44.4% | 19.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| -24.3% | -51.0% | 43.0% | 44.7% | 71.3% | 54.5% | 68.4% | 84.4% | 70.6% | 82.9% | 77.1% | 79.5% | |
| -937.4% | -2,128.7% | -1,401.8% | -2,298.2% | -1,201.1% | -1,595.5% | -946.0% | -461.1% | -817.7% | -464.9% | -541.6% | -435.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 1.4% | 8.5% | 18.5% | 31.9% | 50.9% | 89.6% | 105.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.